Businesswire News Releases

May 07, 2024 06:19 ET
Neurogene Presents Favorable Safety Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome during ASGCT Annual Meeting
Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced initial safety and tolerability data from its ongoing Phase 1/2 gene therapy clinical trial for Rett syndrome, which showed that NGN-401 was generally well-tolerated by all three patients dosed, with follow-up of approximately nine, six and three months post-dosing. These data were presented during the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting....
May 07, 2024 06:06 ET
Broken String Biosciences and the Francis Crick Institute Collaborate to Advance ALS Research
Broken String Biosciences (“Broken String”), a genomics company driving development of the next generation of more precise, safe, and effective cell and gene therapies, today announced it has entered a research collaboration with the Francis Crick Institute, a world-leading biomedical discovery institute dedicated to understanding the biology underlying health and disease....
May 07, 2024 06:03 ET
Gentronix Recognised With King’s Award After Record International Growth
UK-based Contract Research Organisation (CRO) Gentronix – a leading specialist toxicology firm based at Alderley Park – has been awarded the King’s Award for Enterprise after achieving a triple-figure revenue growth following rapid expansion in international markets....
May 07, 2024 06:00 ET
28 Scholars to Research Political Polarization with Support from Carnegie Corporation of New York
Carnegie Corporation of New York announced today the 2024 Class of Andrew Carnegie Fellows. Twenty-eight exceptional fellows will receive stipends of $200,000 each for research that seeks to understand how and why our society has become so polarized and how we can strengthen the forces of cohesion to fortify our democracy....
May 07, 2024 06:00 ET
Abnormal Security Expands Beyond Email, Offering Autonomous AI-Powered Solutions to Protect Humans Across Their Everyday Applications
Abnormal Security, the leader in AI-native human behavior security, today announced that it is expanding its
May 07, 2024 06:00 ET
Allianz Trade & Inclusive Brains join forces to foster the inclusion of people with disabilities thanks to AI and neurotechnologies
Allianz Trade, the world’s leading trade credit insurer and Inclusive Brains, a French start-up ...
May 07, 2024 06:00 ET
Appriss Retail To Participate in Upcoming Events, Including Its U.K. Roadshow, Demonstrating a Commitment To Mitigating Fraud in Europe
Appriss Retail, a leading provider of data and analytics solutions designed to reduce retail losses, decrease returns, and provide a more seamless consumer experience, is highlighting its commitment to the U.K. and EU markets by hosting an exclusive event for customers and prospects, its
May 07, 2024 06:00 ET
Atkore Inc. Announces Second Quarter 2024 Results
Atkore Inc. (the “Company” or “Atkore”) (NYSE: ATKR) announced earnings for its fiscal 2024 second quarter ended March 29, 2024....
May 07, 2024 06:00 ET
Aurinia Will Attend 2024 RBC Capital Markets Global Healthcare Conference
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that it will attend the 2024 RBC Capital Markets Global Healthcare Conference in New York from May 14-15, 2024....
May 07, 2024 06:00 ET
Biodesix to Participate in the 2024 RBCCM Global Healthcare Conference
Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, announced today that Scott Hutton, Chief Executive Officer of Biodesix, will present and host in-person 1x1 investor meetings at the 2024 RBCCM Global Healthcare Conference, which will be held from May 14-15, 2024....
May 07, 2024 06:00 ET
Carrington Mortgage Services Hires Steven Winokur to Continue Its Commitment to Non-QM
Carrington Mortgage Services, LLC (CMS), one of the nation’s largest privately held non-bank lenders, boasts an impressive slate of loan offerings and services direct to consumers, investors, mortgage brokers and mortgage bankers nationwide. As part of its ongoing commitment to expand its non-QM expertise, and provide non-ag...
May 07, 2024 06:00 ET
Excellos Announces Acceleration of Commercialization, New CEO
Excellos Inc., a cell therapy contract and development manufacturing organization (CDMO), today announced it had taken additional investment to accelerate commercialization efforts. As part of the change new CEO Thomas VanCott, Ph.D., will step in to lead the company, while David Wellis, Ph.D., will transfer to Head of Strategic Partnerships....
May 07, 2024 06:00 ET
Flagship Pioneering Unveils Prologue Medicines to Unlock the Therapeutic Potential of the Viral Proteome
Flagship Pioneering, the bioplatform innovation company, today unveiled Prologue Medicines, a company unlocking the therapeutic potential of the viral proteome for the creation of powerful new medicines. Flagship has initially committed $50 million to advance the company’s Decoding Evolutionary Logic of Variant Ensembles (DELVE)™ Platform and harness its power to develop a pipeline of medicines for a wide range of diseases, with an initial focus in immunological, oncology and metabolic indications....
May 07, 2024 06:00 ET
Hercules Capital Announces Upcoming Event for the Financial Community
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that members of the executive management team will be part...
May 07, 2024 06:00 ET
Insulet’s 2023 Sustainability Report Highlights Commitment to Product Accessibility and Responsible Growth
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today released its
May 07, 2024 06:00 ET
Knife River Corporation Reports First Quarter Financial Results
Knife River Corporation (NYSE: KNF), an aggregates-led, vertically integrated construction materials and contracting services company, today announced financial results for the first quarter ended March 31, 2024....
May 07, 2024 06:00 ET
Monomoy Forms Partnership with Leading Residential Exterior Services Platform Southern Exteriors
Monomoy Capital Partners, a private investment firm focused on the middle market, announced today an investment in Southern Exteriors, a full-service installer of exterior building solutions tailored primarily for single-family homebuilders in the Southeastern United States. Management team members, including Southern Exteriors CEO and Founder Aaron Kuhn, will continue to own a meaningful stake in the company....
May 07, 2024 06:00 ET
Monroe Capital Supports LLR Partners and FTV Capital’s Investment in ParkHub and JustPark Merger
Monroe Capital LLC (“Monroe”) announced it acted as sole lead arranger and administrative agent on the funding of a senior credit facility to support the merger and future growth of ParkHub and JustPark by LLR Partners and FTV Capital....
May 07, 2024 06:00 ET
OpenAI Joins C2PA Steering Committee
Today, the Coalition for Content Provenance and Authenticity (C2PA) announced that OpenAI, a leader in artificial intelligence research and deployment, has joined the C2PA as a steering committee member. This marks a significant milestone for the C2PA and will help advance the coalition’s mission to increase transparency around digital media as AI-generated content becomes more prevalent....
May 07, 2024 06:00 ET
Oscar Health Announces Results for First Quarter 2024
Oscar Health, Inc. (“Oscar” or the “Company”) (NYSE: OSCR), a leading healthcare technology company, today announced its financial results for the first quarter ended March 31, 2024....